Is the antiproteinuric effect of cyclosporine a independent of its immunosuppressive function in T cells?

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  Zhang, Bin ^a   Shi, Wei ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866170769     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/809456     Document Type: Review

References (68)

1. Meyrier A., An update on the treatment options for focal segmental glomerulosclerosis. Expert Opinion on Pharmacotherapy 2009 10 4 615 628 2-s2.0-65649089840 10.1517/14656560902754029
2. Shalhoub R. J., Pathogenesis of lipoid nephrosis: a disorder of T cell function. The Lancet 1974 2 7880 556 560 2-s2.0-0016266173
3. Meyrier A. Y., Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis? Kidney International 2009 76 5 487 491 2-s2.0-68949206323 10.1038/ki.2009.204
4. Charbit M., Gubler M. C., Dechaux M., Gagnadoux M. F., Grünfeld J. P., Niaudet P., Cyclosporin therapy in patients with Alport syndrome. Pediatric Nephrology 2007 22 1 57 63 2-s2.0-33846456191 10.1007/s00467-006-0227-y (Pubitemid 46138361)
5. Chen D., Jefferson B., Harvey S. J., Zheng K., Gartley C. J., Jacobs R. M., Thorner P. S., Cyclosporine A slows the progressive renal disease of Alport syndrome (X-linked hereditary nephritis): results from a canine model. Journal of the American Society of Nephrology 2003 14 3 690 698 2-s2.0-0347418134 10.1097/01.ASN.0000046964.15831.16 (Pubitemid 36246013)
6. Ambalavanan S., Fauvel J. P., Sibley R. K., Myers B. D., Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. Journal of the American Society of Nephrology 1996 7 2 290 298 2-s2.0-0029974552 (Pubitemid 26093027)
7. Faul C., Donnelly M., Merscher-Gomez S., Chang Y. H., Franz S., Delfgaauw J., Chang J. M., Choi H. Y., Campbell K. N., Kim K., Reiser J., Mundel P., The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nature Medicine 2008 14 9 931 938 2-s2.0-51349162919 10.1038/nm.1857
8. Wang Y., Jarad G., Tripathi P., Pan M., Cunningham J., Martin D. R., Liapis H., Miner J. H., Chen F., Activation of NFAT signaling in podocytes causes glomerulosclerosis. Journal of the American Society of Nephrology 2010 21 10 1657 1666 2-s2.0-77957868187 10.1681/ASN.2009121253
9. Nijenhuis T., Sloan A. J., Hoenderop J. G. J., Flesche J., van Goor H., Kistler A. D., Bakker M., Bindels R. J. M., de Boer R. A., Möller C. C., Hamming I., Navis G., Wetzels J. F. M., Berden J. H. M., Reiser J., Faul C., van der Vlag J., Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. American Journal of Pathology 2011 179 4 1719 1732 2-s2.0-80053282316 10.1016/j.ajpath.2011.06.033
10. Reiser J., Gupta V., Kistler A. D., Toward the development of podocyte-specific drugs. Kidney International 2010 77 8 662 668 2-s2.0-77950517549 10.1038/ki.2009.559
11. + channels: different effects in embryonic neurons and podocytes. American Journal of Physiology 2009 297 6 C1379 C1388 2-s2.0-73449109561 10.1152/ajpcell.00354.2009
12. Mundel P., Reiser J., Proteinuria: an enzymatic disease of the podocyte. Kidney International 2010 77 7 571 580 2-s2.0-77949541746 10.1038/ki.2009.424
13. Somlo S., Mundel P., Getting a foothold in nephrotic syndrome. Nature Genetics 2000 24 4 333 335 2-s2.0-0034126357 10.1038/74139 (Pubitemid 30187426)
14. Tryggvason K., Patrakka J., Wartiovaara J., Hereditary proteinuria syndromes and mechanisms of proteinuria. New England Journal of Medicine 2006 354 13 1387 1401 2-s2.0-33645403170 10.1056/NEJMra052131
15. Oh J., Reiser J., Mundel P., Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome. Pediatric Nephrology 2004 19 2 130 137 2-s2.0-0842280714 10.1007/s00467-003-1367-y (Pubitemid 38181002)
16. Löwik M. M., Groenen P. J. T. A., Pronk I., Lilien M. R., Goldschmeding R., Dijkman H. B., Levtchenko E. N., Monnens L. A., Van Den Heuvel L. P., Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney International 2007 72 10 1198 1203 2-s2.0-35848933493 10.1038/sj.ki.5002469 (Pubitemid 350059656)
17. Yaddanapudi S., Altintas M. M., Kistler A. D., Fernandez I., Möller C. C., Wei C., Peev V., Flesche J. B., Forst A. L., Li J., Patrakka J., Xiao Z., Grahammer F., Schiffer M., Lohmüller T., Reinheckel T., Gu C., Huber T. B., Ju W., Bitzer M., Rastaldi M. P., Ruiz P., Tryggvason K., Shaw A. S., Faul C., Sever S., Reiser J., CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival. Journal of Clinical Investigation 2011 121 10 3965 3980 2-s2.0-80053439688 10.1172/JCI58552
18. Kestilä M., Lenkkeri U., Männikkö M., Lamerdin J., McCready P., Putaala H., Ruotsalainen V., Morita T., Nissinen M., Herva R., Kashtan C. E., Peltonen L., Holmberg C., Olsen A., Tryggvason K., Positionally cloned gene for a novel glomerular proteinnephrinis mutated in congenital nephrotic syndrome. Molecular Cell 1998 1 4 575 582 2-s2.0-0032015551 (Pubitemid 128374693)
19. Hinkes B., Wiggins R. C., Gbadegesin R., Vlangos C. N., Seelow D., Nürnberg G., Garg P., Verma R., Chaib H., Hoskins B. E., Ashraf S., Becker C., Hennies H. C., Goyal M., Wharram B. L., Schachter A. D., Mudumana S., Drummond I., Kerjaschki D., Waldherr R., Dietrich A., Ozaltin F., Bakkaloglu A., Cleper R., Basel-Vanagaite L., Pohl M., Griebel M., Tsygin A. N., Soylu A., Müller D., Sorli C. S., Bunney T. D., Katan M., Liu J., Attanasio M., O'Toole J. F., Hasselbacher K., Mucha B., Otto E. A., Airik R., Kispert A., Kelley G. G., Smrcka A. V., Gudermann T., Holzman L. B., Nürnberg P., Hildebrandt F., Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nature Genetics 2006 38 12 1397 1405 2-s2.0-33751531864 10.1038/ng1918 (Pubitemid 44837561)
20. Boute N., Gribouval O., Roselli S., Benessy F., Lee H., Fuchshuber A., Dahan K., Gubler M. C., Niaudet P., Antignac C., NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nature Genetics 2000 24 4 349 354 2-s2.0-0034034757 10.1038/74166 (Pubitemid 30187431)
21. Winn M. P., Conlon P. J., Lynn K. L., Farrington M. K., Creazzo T., Hawkins A. F., Daskalakis N., Kwan S. Y., Ebersviller S., Burchette J. L., Pericak-Vance M. A., Howell D. N., Vance J. M., Rosenberg P. B., Medicine: a mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005 308 5729 1801 1804 2-s2.0-20844461826 10.1126/science.1106215 (Pubitemid 40848011)
22. Reiser J., Polu K. R., Möller C. C., Kenlan P., Altintas M. M., Wei C., Faul C., Herbert S., Villegas I., Avila-Casado C., McGee M., Sugimoto H., Brown D., Kalluri R., Mundel P., Smith P. L., Clapham D. E., Pollak M. R., TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nature Genetics 2005 37 7 739 744 2-s2.0-22844436647 10.1038/ng1592 (Pubitemid 41754891)
23. Brown E. J., Schlöndorff J. S., Becker D. J., Tsukaguchi H., Uscinski A. L., Higgs H. N., Henderson J. M., Pollak M. R., Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nature Genetics 2010 42 1 72 76 2-s2.0-73349132341 10.1038/ng.505
24. Mele C., Iatropoulos P., Donadelli R., Calabria A., Maranta R., Cassis P., Buelli S., Tomasoni S., Piras R., Krendel M., Bettoni S., Morigi M., Delledonne M., Pecoraro C., Abbate I., Capobianchi M. R., Hildebrandt F., Otto E., Schaefer F., Macciardi F., Ozaltin F., Emre S., Ibsirlioglu T., Benigni A., Remuzzi G., Noris M., MYO1E mutations and childhood familial focal segmental glomerulosclerosis. New England Journal of Medicine 2011 365 4 295 306 2-s2.0-79960877647 10.1056/NEJMoa1101273
25. Faul C., Asanuma K., Yanagida-Asanuma E., Kim K., Mundel P., Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends in Cell Biology 2007 17 9 428 437 2-s2.0-34848907421 10.1016/j.tcb.2007.06.006 (Pubitemid 47499042)
26. Togawa A., Miyoshi J., Ishizaki H., Tanaka M., Takakura A., Nishioka H., Yoshida H., Doi T., Mizoguchi A., Matsuura N., Niho Y., Nishimune Y., Nishikawa S. I., Takai Y., Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDI α Oncogene 1999 18 39 5373 5380 2-s2.0-0033598349 10.1038/sj.onc.1202921 (Pubitemid 29469225)
27. Shibata S., Nagase M., Yoshida S., Kawarazaki W., Kurihara H., Tanaka H., Miyoshi J., Takai Y., Fujita T., Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nature Medicine 2008 14 12 1370 1376 2-s2.0-57349168398 10.1038/nm.1879
28. Schmieder S., Nagai M., Orlando R. A., Takeda T., Farquhar M. G., Podocalyxin activates RhoA and induces actin reorganization through NHERF1 and Ezrin in MDCK cells. Journal of the American Society of Nephrology 2004 15 9 2289 2298 2-s2.0-4344716629 10.1097/01.ASN.0000135968.49899.E8 (Pubitemid 39159329)
29. Moeller M. J., Soofi A., Braun G. S., Li X., Watzl G., Kriz W., Holzman L. B., Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. The EMBO Journal 2004 23 19 3769 3779 2-s2.0-6344276685 10.1038/sj.emboj.7600380 (Pubitemid 39389708)
30. Jones N., Blasutig I. M., Eremina V., Ruston J. M., Bladt F., Li H., Huang M., Larose L., Li S. S. C., Takano T., Quaggin S. E., Pawson T., Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006 440 7085 818 823 2-s2.0-33645746950 10.1038/nature04662
31. Asanuma K., Yanagida-Asanuma E., Faul C., Tomino Y., Kim K., Mundel P., Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nature Cell Biology 2006 8 5 485 491 2-s2.0-33744969296
32. Schlöndorff J. S., Pollak M. R., TRPC6 in glomerular health and disease: what we know and what we believe. Seminars in Cell and Developmental Biology 2006 17 6 667 674 2-s2.0-33846452505 10.1016/j.semcdb.2006.11.003 (Pubitemid 46138163)
33. Möller C. C., Wei C., Altintas M. M., Li J., Greka A., Ohse T., Pippin J. W., Rastaldi M. P., Wawersik S., Schiavi S., Henger A., Kretzler M., Shankland S. J., Reiser J., Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. Journal of the American Society of Nephrology 2007 18 1 29 36 2-s2.0-33846028228 10.1681/ASN.2006091010 (Pubitemid 46053419)
34. -/- mice. Molecular and Cellular Biology 2005 25 16 6980 6989 2-s2.0-23344454472 10.1128/MCB.25.16.6980-6989.2005 (Pubitemid 41105898)
35. Mundel P., Heid H. W., Mundel T. M., Krüger M., Reiser J., Kriz W., Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. Journal of Cell Biology 1997 139 1 193 204 2-s2.0-0030816323 10.1083/jcb.139.1.193 (Pubitemid 27444091)
36. Heeringa S. F., Möller C. C., Du J., Yue L., Hinkes B., Chernin G., Vlangos C. N., Hoyer P. F., Reiser J., Hildebrandt F., A novel TRPC6 mutation that causes childhood FSGS. PLoS One 2009 4 11, article e7771 2-s2.0-70450164319 10.1371/journal.pone.0007771
37. Huber T. B., Kwoh C., Wu H., Asanuma K., Gödel M., Hartleben B., Blumer K. J., Miner J. H., Mundel P., Shaw A. S., Bigenic mouse models of focal segmental glomerulosclerosis involving pairwise interaction of CD2AP, Fyn, and synaptopodin. Journal of Clinical Investigation 2006 116 5 1337 1345 2-s2.0-33646406847 10.1172/JCI27400
38. Yanagida-Asanuma E., Asanuma K., Kim K., Donnelly M., Hoon Y. C., Jae H. C., Suetsugu S., Tomino Y., Takenawa T., Faul C., Mundel P., Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. American Journal of Pathology 2007 171 2 415 427 2-s2.0-34548324281 10.2353/ajpath.2007.070075 (Pubitemid 47344675)
39. Wei C., Möller C. C., Altintas M. M., Li J., Schwarz K., Zacchigna S., Xie L., Henger A., Schmid H., Rastaldi M. P., Cowan P., Kretzler M., Parrilla R., Bendayan M., Gupta V., Nikolic B., Kalluri R., Carmeliet P., Mundel P., Reiser J., Modification of kidney barrier function by the urokinase receptor. Nature Medicine 2008 14 1 55 63 2-s2.0-38049032013 10.1038/nm1696
40. Wei C., El Hindi S., Li J., Fornoni A., Goes N., Sageshima J., Maiguel D., Karumanchi S. A., Yap H. K., Saleem M., Zhang Q., Nikolic B., Chaudhuri A., Daftarian P., Salido E., Torres A., Salifu M., Sarwal M. M., Schaefer F., Morath C., Schwenger V., Zeier M., Gupta V., Roth D., Rastaldi M. P., Burke G., Ruiz P., Reiser J., Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nature Medicine 2011 17 8 952 960 2-s2.0-79961132981 10.1038/nm.2411
41. Blasi F., Carmeliet P., uPAR: a versatile signalling orchestrator. Nature Reviews Molecular Cell Biology 2002 3 12 932 943 2-s2.0-0036906177 10.1038/nrm977 (Pubitemid 35477371)
42. Zhang B., Xie S., Shi W., Yang Y., Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria. Nephrology Dialysis Transplantation 2012 27 5 1746 1755 10.1093/ndt/gfr612
43. Wu H., Peisley A., Graef I. A., Crabtree G. R., NFAT signaling and the invention of vertebrates. Trends in Cell Biology 2007 17 6 251 260 2-s2.0-34249673350 10.1016/j.tcb.2007.04.006 (Pubitemid 46829850)
44. Rao A., Signaling to gene expression: calcium, calcineurin and NFAT. Nature Immunology 2009 10 1 3 5 2-s2.0-57849107130 10.1038/ni0109-3
45. Crabtree G. R., Calcium, calcineurin, and the control of transcription. Journal of Biological Chemistry 2001 276 4 2313 2316 2-s2.0-0035951849 10.1074/jbc.R000024200
46. Graef I. A., Chen F., Crabtree G. R., NFAT signaling in vertebrate development. Current Opinion in Genetics and Development 2001 11 5 505 512 2-s2.0-0035479991 10.1016/S0959-437X(00)00225-2 (Pubitemid 32800723)
47. Crabtree G. R., Olson E. N., NFAT signaling: choreographing the social lives of cells. Cell 2002 109 2 S67 S79 2-s2.0-0036234543 10.1016/S0092-8674(02) 00699-2 (Pubitemid 34457853)
48. 3 integrin. Journal of Biological Chemistry 2004 279 33 34827 34832 2-s2.0-4544377833 10.1074/jbc.M401973200 (Pubitemid 39318116)
49. Sever S., Altintas M. M., Nankoe S. R., Möller C. C., Ko D., Wei C., Henderson J., Del Re E. C., Hsing L., Erickson A., Cohen C. D., Kretzler M., Kerjaschki D., Rudensky A., Nikolic B., Reiser J., Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease. Journal of Clinical Investigation 2007 117 8 2095 2104 2-s2.0-34547654202 10.1172/JCI32022 (Pubitemid 47219554)
50. Reiser J., von Gersdorff G., Loos M., Oh J., Asanuma K., Giardino L., Rastaldi M. P., Calvaresi N., Watanabe H., Schwarz K., Faul C., Kretzler M., Davidson A., Sugimoto H., Kalluri R., Sharpe A. H., Kreidberg J. A., Mundel P., Induction of B7-1 in podocytes is associated with nephrotic syndrome. Journal of Clinical Investigation 2004 113 10 1390 1397 2-s2.0-2942561024 10.1172/JCI200420402 (Pubitemid 39071694)
51. Reiser J., Mundel P., Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome. Journal of the American Society of Nephrology 2004 15 9 2246 2248 2-s2.0-4344680956 10.1097/01.ASN.0000136312.46464.33 (Pubitemid 39159324)
52. Li S. Z., McDill B. W., Kovach P. A., Ding L., Go W. Y., Ho S. N., Chen F., Calcineurin-NFATc signaling pathway regulates AQP2 expression in response to calcium signals and osmotic stress. American Journal of Physiology 2007 292 5 C1606 C1616 2-s2.0-34250615503 10.1152/ajpcell.00588.2005 (Pubitemid 47080556)
53. Anderson M., Suh J. M., Kim E. Y., Dryer S. E., Functional NMDA receptors with atypical properties are expressed in podocytes. American Journal of Physiology 2011 300 1 C22 C32 2-s2.0-78651354592 10.1152/ajpcell.00268.2010
54. Ca channels by synaptopodin, Rho, and actin microfilaments. American Journal of Physiology 2010 299 3 F594 F604 2-s2.0-77956460099 10.1152/ajprenal.00206.2010
55. Greka A., Mundel P., Balancing calcium signals through TRPC5 and TRPC6 in podocytes. Journal of the American Society of Nephrology 2011 22 11 1969 1980 2-s2.0-80555134770 10.1681/ASN.2011040370
56. 2+ signaling by recruitment and activation of phospholipase C- γ 1. Journal of Biological Chemistry 2009 284 13 8951 8962 2-s2.0-67649778673 10.1074/jbc.M806851200
57. Vassiliadis J., Bracken C., Matthews D., O'Brien S., Schiavi S., Wawersik S., Calcium mediates glomerular filtration through calcineurin and mTORC2/Akt signaling. Journal of the American Society of Nephrology 2011 22 8 1453 1461 2-s2.0-79960936436 10.1681/ASN.2010080878
58. Schlöndorff J., del Camino D., Carrasquillo R., Lacey V., Pollak M. R., TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. American Journal of Physiology 2009 296 3 C558 C569 2-s2.0-65249099647 10.1152/ajpcell.00077.2008
59. Moeller M. J., Sanden S. K., Soofi A., Wiggins R. C., Holzman L. B., Podocyte-specific expression of Cre recombinase in transgenic mice. Genesis 2003 35 1 39 42 2-s2.0-0037247603 10.1002/gene.10164 (Pubitemid 36150980)
60. Belteki G., Haigh J., Kabacs N., Haigh K., Sison K., Costantini F., Whitsett J., Quaggin S. E., Nagy A., Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Research 2005 33 5 e51 2-s2.0-20144389673
61. Tian D., Jacobo S. M. P., Billing D., Rozkalne A., Gage S. D., Anagnostou T., Pavenstaedt H., Hsu H. H., Schlondorff J., Ramos A., Greka A., Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Science Signaling 2010 3 145, article ra77 2-s2.0-78049524253 10.1126/scisignal.2001200
62. Wang L., Chang J. H., Paik S. Y., Tang Y., Eisner W., Spurney R. F., Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo. Molecular Endocrinology 2011 25 8 1376 1386 2-s2.0-79960972131 10.1210/me.2011-0029
63. Winslow M. M., Pan M., Starbuck M., Gallo E. M., Deng L., Karsenty G., Crabtree G. R., Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Developmental Cell 2006 10 6 771 782 2-s2.0-33646890016 10.1016/j.devcel.2006. 04.006 (Pubitemid 43779111)
64. Pan M., Winslow M. M., Chen L., Kuo A., Felsher D., Crabtree G. R., Enhanced NFATc1 nuclear occupancy causes T cell activation independent of CD28 costimulation. Journal of Immunology 2007 178 7 4315 4321 2-s2.0-33947669503 (Pubitemid 46492382)
65. Heit J. J., Apelqvist A. A., Gu X., Winslow M. M., Neilson J. R., Crabtree G. R., Kim S. K., Calcineurin/NFAT signalling regulates pancreatic β -cell growth and function. Nature 2006 443 7109 345 349 2-s2.0-33748929299 10.1038/nature05097 (Pubitemid 44435154)
66. Lee M. Y., Garvey S. M., Baras A. S., Lemmon J. A., Gomez M. F., Schoppee Bortz P. D., Daum G., LeBoeuf R. C., Wamhoff B. R., Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells. Human Molecular Genetics 2009 19 3 468 479 2-s2.0-77949892204 10.1093/hmg/ddp511
67. Liu Q., Busby J. C., Molkentin J. D., Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Nature Cell Biology 2009 11 2 154 161 2-s2.0-59649116320 10.1038/ncb1823
68. Dai C., Stolz D. B., Kiss L. P., Monga S. P., Holzman L. B., Liu Y., Wnt/ β -catenin signaling promotes podocyte dysfunction and albuminuria. Journal of the American Society of Nephrology 2009 20 9 1997 2008 2-s2.0-69849089270 10.1681/ASN.2009010019